SCOR Lifts Group Solvency Ratio to 220% as Reinsurer Rebuilds Capital Buffers

SCOR Lifts Group Solvency Ratio to 220% as Reinsurer Rebuilds Capital Buffers

SCOR's Group solvency ratio rose to 220% in Q2 2026, net of a dividend accrual, growth capital deployment and deleveraging — ahead of 2027 renewals.

SCOR’s Group solvency ratio climbed to 220% at the end of Q2 2026, up 5 percentage points versus FY 2025, and the reinsurer says the gain already absorbed a dividend accrual, fresh growth capital and deleveraging moves rather than being achieved despite them. The rebuild caps a stretch in which SCOR spent 2023 and 2024 defending its balance sheet, and it lands roughly three months before the 2027 treaty renewal season begins in earnest.

Five points, and what they were paid for

The headline number, disclosed in SCOR’s second-quarter 2026 results, is less interesting than what it had to survive. SCOR states plainly that the reported 220% solvency ratio already factors in the accrual of a dividend for the first half of 2026, alongside capital deployment for growth and deleveraging actions. In practice, that means the reinsurer paid for the five-point improvement three times over: once by setting aside a shareholder payout, once by continuing to fund new business, and once by reducing leverage, and still came out ahead. Chief executive Thierry Léger said the Group solvency ratio stood at 220% at the end of Q2 2026, with capital generation in line with SCOR’s FY 2026 guidance, framing the quarter as on-plan rather than exceptional.

SCOR’s Board of Directors met on 29 July 2026, under the chairmanship of Fabrice Brégier, to approve the Group’s Q2 2026 financial statements, a day before the figures were made public. The timing is routine, but the substance is not: a reinsurer that spent much of the post-2022 period rationing capital is now signalling that it has room to deploy it again, a posture visible in SCOR’s broader growth push, including its recently announced memorandum of understanding with Japan Post Insurance on postal life reinsurance.

A combined ratio that owes less to luck than it looks

Underwriting did most of the work. SCOR’s P&C combined ratio was 79.5% in Q2 2026, reflecting benign nat cat experience, strong attritional loss performance and additional reserve buffer building, a phrasing that matters because it signals reserves were topped up rather than released to flatter the headline. Broken down further, the Q2 2026 P&C combined ratio of 79.5% included a natural catastrophe ratio of 2.9%, reflecting a benign quarter of low natural catastrophe activity, per the second-quarter 2026 results release. SCOR was not alone in that respect: the quarter added up to a benign nat cat half for reinsurers broadly, a pattern Munich Re’s own first-half 2026 catastrophe-loss disclosures reinforced from the largest competitor’s side of the ledger.

The rest of the P&L held up around that underwriting result. Investments generated a regular income yield of 3.6% in Q2 2026, with reinvestment rates still attractive, while SCOR posted EUR 171 million net income in Q2 2026, bringing net income to EUR 397 million for H1 2026, a first-half figure SCOR separately reports as EUR 397 million, or EUR 409 million on an adjusted basis. Annualized Return on Equity was 16.3%, or 18.0% adjusted, in Q2 2026, against an effective tax rate of 24.1% for the quarter. Economic value moved in the same direction: SCOR’s IFRS 17 Group Economic Value reached EUR 9.0 billion as at 30 June 2026, up 10.5% at constant economics versus 31 December 2025. None of this happens in isolation. The improvement is part of a broader continental trend of rising solvency ratios among European insurers through 2025 and into 2026, which raises a fair question: how much of SCOR’s five points is company-specific execution, and how much is a rising tide lifting the whole reinsurance sector.

The arbitration line the results do not hide

SCOR did not bury the quarter’s weak spot. In Life & Health, the insurance service result stood at EUR 49 million in Q2 2026, dragged down by a negative experience variance tied to a one-off arbitration outcome. SCOR frames the item as isolated, and nothing in the disclosure points to a recurring pattern of adverse experience across the wider L&H book. But the transparency of the framing is itself worth noting: a reinsurer eager to sell an unblemished capital-rebuild story could have relegated the arbitration outcome to a footnote or omitted the causal link altogether. Instead, it sits in the same results release as the 220% solvency ratio and the double-digit Return on Equity, a reminder that the quarter’s good news was not universal across every segment of the business, and that L&H remains the line to watch as SCOR heads into the second half of the year.

What cedants will bring to the 2027 renewal table

Capital strength only travels as far as rating agencies are willing to certify it, and on that front SCOR’s trajectory has been improving for well over a year. On 14 October 2025, Fitch Ratings revised the outlook on SCOR SE and its core operating subsidiaries to Positive from Stable, while affirming their Insurer Financial Strength rating at A+ and Long-Term Issuer Default Rating at A, a change tracked on the page SCOR maintains for its credit ratings and outlooks. Earlier the same cycle, on 23 January 2025, AM Best removed SCOR SE from under review and affirmed its Financial Strength Rating of A, Excellent, for SCOR SE and its main operating subsidiaries, with a stable outlook, closing off a period of agency uncertainty that had shadowed the reinsurer since its capital-strengthening years.

Both rating actions predate these second-quarter results, which means the market had already been given reason to expect a firmer balance sheet before SCOR delivered one. Put together, the sequence, Positive outlooks, an under-review flag lifted, and now a solvency ratio that rose even after paying for growth, dividends and deleveraging, is the argument SCOR’s underwriters will carry into 2027 treaty negotiations. Cedants shopping capacity in a market where reinsurer discipline has been the dominant story since 2023 will be looking for exactly this: a counterparty that can show its capital position improved, not merely stabilized. Whether that translates into softer terms or simply steadier capacity commitments will be the real test of the next renewal cycle.

Mini-FAQ

How much did SCOR’s Group solvency ratio rise in the second quarter?
SCOR’s Group solvency ratio is estimated at 220% at the end of Q2 2026, up 5 percentage points versus FY 2025, a figure that already reflects a dividend accrual plus growth and deleveraging spending.
Why did SCOR’s life and health business underperform this quarter?
SCOR’s L&H insurance service result stood at EUR 49 million in Q2 2026, dragged down by a negative experience variance tied to a one-off arbitration outcome, which the reinsurer treats as an isolated item rather than a trend.
Have rating agencies changed their view of SCOR recently?
Yes. Fitch Ratings revised SCOR’s outlook to Positive from Stable on 14 October 2025 while affirming its ratings at A+ and A, and AM Best removed SCOR from under review and affirmed its Financial Strength Rating of A, Excellent, with a stable outlook on 23 January 2025.

Sources

P

Patrice Dumont

InsuraBeat correspondent

Senior reporter at InsuraBeat leading coverage of insurance regulation, executive moves, and the insurtech landscape across EMEA and APAC. Fifteen years straddling regulation and trade journalism: began in the legal team of a French insurance industry body, advising members on Solvency II implementation and product approvals, then moved to specialised insurance media to cover EIOPA, NAIC and IAIS work and prudential reform. Graduate of the Pan-Asian School of Governance and Regulatory Affairs (Singapore), with an LL.M. in Insurance Prudential Law and Cross-Border Compliance from the Nihon-Siam Institute of Legal Studies (Bangkok). Writes from Brussels, on European afternoon markets.

All articles by Patrice Dumont →

Daily Beat newsletter

Never miss a beat in global insurance.

Get the day’s top deals, executive moves and regulatory shifts in your inbox every morning.

Free. No spam. Unsubscribe anytime.